Beijing Wandong Medical Technology Co., Ltd. / Fundamentals
Income statement
- Net revenue
€188.43M - Cost of goods sold
€120.35M - Gross profit
€68.08M - SG&A expenses
€22.95M - R&D expenses
€21.18M - EBITDA
€19.66M - D&A
€1.19M - EBIT
€17.16M - Interest expenses
€319.26K - EBT
€20.03M - Tax expenses
€1.05M - Net income
€18.94M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€26.91M - Changes in working capital
-€2.65M - Operating cash flow
€31.79M - Capex
€6.50M - Other investing cash flow
€2.11M - Net investing cash flow
-€189.53M - Total cash dividends paid
-€10.87M - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
-€11.52M - Net financing cash flow
-€11.53M - Foreign exchange effects
€0.00 - Net change in cash
-€190.25M - Cash at end of period
€168.50M - Free cash flow
€38.29M
Balance sheet
- Cash and cash equivalents
€356.80M - Cash and short-term investments
€398.14M - Total receivables
€63.73M - Inventory
€23.53M - Other current assets
€35.03M - Total current assets
€520.43M - Property, plant & equipment
€30.62M - Goodwill
€0.00 - Intangible assets
€7.93M - Long-term investments
€1.09M - Other non-current assets
€73.24M - Total non-current assets
€121.72M - Total assets
€642.15M - Accounts payable
€22.57M - Short-term debt
€0.00 - Other current liabilities
€27.80M - Total current liabilities
€52.28M - Long-term debt
€1.83M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€2.59M - Total non-current liabilities
€5.37M - Total liabilities
€57.65M - Common stock
€83.65M - Retained earnings
€130.09M - Other equity
€0.00 - Total equity
€584.50M - Total liabilities and shareholders' equity
€642.15M
Company information
- Market capitalization
€1.45B - Employees
1.1K - Enterprise Value
€9.76B
Company ratios
- Gross margin
-
36.1% Worse than peer group: 46.2% - EBITDA margin
-
10.4% Worse than peer group: 22.2% - EBIT margin
-
9.1% Even with peer group: 10.9% - EBT margin
-
10.6% Worse than peer group: 16.1% - Net margin
-
10.0% Even with peer group: 13.5% - ROE
-
3.2% Worse than peer group: 14.6% - ROA
-
2.9% Even with peer group: 7.6% - Asset turnover
-
29.3% Much worse than peer group: 64.5% - FCF margin
-
13.4% Better than peer group: -0.9% - FCF yield
1.7% - Efficiency ratio
89.6% - Net sales per employee
-
€177.93K - Net income per employee
-
€17.88K